Akebia Therapeutics Prices $50 Million Public Offering

, MT Newswires -  4:08 AM ET 3/20/2025 Company News

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print

04:08 AM EDT, 03/20/2025 (MT Newswires) -- Akebia Therapeutics ( AKBA ) said late Wednesday it priced its underwritten public offering of 25 million shares at $2 per share to raise about $50 million in gross proceeds.

The company said it also granted underwriters a 30-day option to purchase up to 3.8 million additional shares at the offering price.

The offering is expected to close on March 21.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

© 1999-2025 Midnight Trader, Inc. All rights reserved.

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print
close
Please enter a valid e-mail address
Please enter a valid e-mail address
Important legal information about the e-mail you will be sending. By using this service, you agree to input your real e-mail address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an e-mail. All information you provide will be used by Fidelity solely for the purpose of sending the e-mail on your behalf.The subject line of the e-mail you send will be "Fidelity.com: "

Your e-mail has been sent.
close

Your e-mail has been sent.